Category Archives: News
Midodrine is effective for orthostatic hypotension
Research abstract: OBJECTIVE Midodrine hydrochloride is a short-acting pressor agent that raises blood pressure in the upright position in patients with orthostatic hypotension. The US Food and Drug Administration’s Subpart H approval, under which midodrine was initially approved, requires post-marketing … Continue reading
Creativity and illness: Marion’s story on Radio 4
Women’s Hour on BBC Radio Four: “Creativity and illness: Marion’s Story” Marion Michell has lived with ME and chronic fatigue for the last 17 years. She talks about how she became an artist through rediscovering crochet. Listen to Marion [Duration: … Continue reading
Lancet invites letter re PACE, then decides not to publish
Virology blog post, by Vincent Racaniello, 29 August 2016: Once Again, Lancet Stumbles on PACE Last February, Virology Blog posted an open letter to The Lancet and its editor, Dr. Richard Horton, describing the indefensible flaws of the PACE trial … Continue reading
Protein kinase gene dysfunction in severe CFS/ME
Research abstract: Background: The etiology and pathomechanism of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) are unknown. However, natural killer (NK) cell dysfunction, in particular reduced NK cytotoxic activity, is a consistent finding in CFS/ME patients. Previous research has reported significant changes … Continue reading
MRI of hearts of women with CFS found lower left ventricular function
Research abstract: Objective: In chronic fatigue syndrome (CFS), only a few imaging and histopathological studies have previously assessed either cardiac dimensions/function or myocardial tissue, suggesting smaller left ventricular (LV) dimensions, LV wall motion abnormalities and occasionally viral persistence that may … Continue reading
Post-exertional malaise: an exploratory factor analysis
Research abstract: Post-exertional malaise is a cardinal symptom of myalgic encephalomyelitis and chronic fatigue syndrome. There are two differing focuses when defining post-exertional malaise: a generalized, full-body fatigue and a muscle-specific fatigue. This study aimed to discern whether post-exertional malaise … Continue reading
Ampligen – the first drug approved in the world for ME/CFS
Health rising blog post, by Cort Johnson, 25 August, 2016: Ampligen Takes Big Step Forward – Becomes First Drug Approved Anywhere For Chronic Fatigue Syndrome Ampligen became the first drug approved for chronic fatigue syndrome (ME/CFS) anywhere in the world … Continue reading
